Clin2
NCT06057051Likely a fitRecruiting

Stent implant for mild to moderate open-angle glaucoma

Glaucoma

Part of Eyes & vision clinical trials.

This trial studies a tiny implant called iStent Infinite that helps drain fluid from the eye to lower pressure in people with mild to moderate open-angle glaucoma. It may offer a new way to manage the condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
245 people
Ages
35 years and older
Study type
Interventional

Who can take part

  • You have primary open-angle glaucoma (the most common type of glaucoma).
  • Your glaucoma is mild to moderate, not advanced.
  • You are 35 years old or older.
  • Your eye lens is either natural (phakic) or replaced with an artificial lens (pseudophakic).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07354009Recruiting
Stent implant for lowering eye pressure in open-angle glaucoma

This trial tests a small stent to help drain fluid from the eye and lower pressure in people who have both open-angle glaucoma and cataracts. The stent is placed during routine cataract surgery.

Hangzhou
NCT07009236Recruiting
MINIject S+ for open angle glaucoma

This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.

Santa Rosa de Copán
NCT07531199Not yet recruiting
Testing a New Glaucoma Surgery Implant to Prevent Low Eye Pressure

This trial tests a tiny implant called Preserflo to treat glaucoma (high eye pressure) that hasn't been controlled with eyedrops. The surgery aims to lower pressure safely while avoiding complications like pressure that drops too low.

NCT07228221Recruiting· Phase 4
Study of iStent and iDose for moderate to severe glaucoma

This trial studies a new treatment (a tiny device called iStent Infinite and a medication implant) for people with moderate to severe open-angle glaucoma who have not responded well to drops or laser. The goal is to see if this treatment can lower eye pressure and help avoid traditional surgery.

Philadelphia, Pennsylvania
NCT06066645Recruiting· Phase 4
Travoprost implant plus iStent for glaucoma

This trial tests a tiny implant that slowly releases travoprost (a pressure-lowering medicine) inside the eye, combined with a small stent (iStent) to help drain fluid. It's for people with open-angle glaucoma or high eye pressure who need to lower their eye pressure.

Oklahoma City, Oklahoma
NCT06607705Recruiting
Eye pressure changes after iStent surgery with a contact lens sensor

This study tests a tiny implant (iStent inject W) that helps lower eye pressure in people with open-angle glaucoma. A special contact lens sensor will monitor your eye pressure after surgery. The goal is to see how well the implant works and how it changes your eye pressure throughout the day.

Barcelona, Spain

Hear when a new Glaucoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.